All articles tagged with #serapha bio
Beam Therapeutics has filed a lawsuit against YolTech Therapeutics and Serapha Bio, alleging that a former scientist stole trade secrets to develop a competing therapy for alpha-1 antitrypsin deficiency. The suit claims the former employee accessed confidential records off-hours while employed by Beam. Serapha Bio has denied the allegations, while YolTech has not responded.
Beam Therapeutics has filed a lawsuit in Massachusetts against YolTech Therapeutics and Serapha Bio, alleging that former employee Zi Jun 'Emma' Wang stole proprietary base editing data to develop a competing therapy for alpha-1 antitrypsin deficiency. The suit claims Wang accessed confidential records off-hours while employed by Beam, leading to the creation of a rival drug candidate that targets the same genetic mutation as Beam's lead program. Serapha Bio has denied the allegations, while YolTech has not responded.